Background/Aim. Gastric cancer (GC) is fourth most frequent malignant tumor worldwide, frequently diagnosed at advanced stages with poor prognosis. The aim of study was to determine expression of IL-32, pro-inflammatory and angiogenic mediators in tumor, peritumor and healthy tissue, in patients with intestinal gastric cancer and the relationship with disease severity. Methods. The tissue samples of intestinal types of tumor of 60 patients with gastric cancer were analyzed. Expression of IL-32, Vascular endothelial growth factor (VEGF), IL-17 and CD31 were measured by immunohistochemistry. Results. IL-32, VEGF and IL-17 expression as well as microvascular density (MVD) were diminished in adjacent tumor tissues compared with tumor tissues. Further, more intense expression of IL-32 and VEGF and enhanced MVD were noticed in patients with severe (TNM stages III and IV) and more progressive GC (lymph vessel invasion). Conclusions. Higher expression of IL-32, VEGF and intense MVD in tumor tissue of GC patients with detectable lymph vessel invasion may be considered as a sign of the tumor's malignant progression. This emphasizes on protumorogenic and proangiogenic role of IL-32 in biology of intestinal type of gastric cancer.
ApstraktUvod/Cilj. Karcinom želuca (engl. Gastric cancer-GC) je četvrti najčešći maligni tumor širom sveta, često dijagnostikovan u naprednim stadijumima sa lošom prognozom. Cilj studije je bio da se utvrdi ekspresija IL-32, pro-inflamatornih i angiogenih medijatora u tumoru, peritumoru i zdravom tkivu kod pacijenata sa intestinalnim tipom karcinoma želuca kao i povezanost sa težinom bolesti. Metode. Uzorci tkiva intestinalnog tipa tumora od 60 pacijenata sa karcinomom želuca su analizirani u studiji. Ekspresija IL-32, Vaskularnog endotelnog faktora rasta (engl. Vascular endothelial growth factor-VEGF), IL-17 i CD31 je merena imunohistohemijskom metodom. Rezultati. Ekspresija IL-32, VEGF-a i IL-17 kao i mikrovaskularna gustina (engl. Microvascular density-MVD) su smanjeni u peri-tumorskom tkivu u poređenju sa tumorskim tkivom. Intenzivnija ekspresija IL-32 i VEGF-a i pojačana MVD registrovani su kod pacijenata sa težim (TNM stadijumi III i IV) i progresivnijim karcinomom želuca (prisutna invazija limfnih sudova). Zaključak. Veća ekspresija IL-32, VEGF-a i intenzivnija MVD u tumorskom tkivu bolesnika sa karcinomom želuca i prisutnom invazijom limfnih sudova može se smatrati znakom progresije maligne bolesti. Ovaj rezultat ukazuje na protumorogenu i proangiogenu ulogu IL-32 u biologiji intestinalnog tipa karcinoma želuca.Ključne reči: karcinom želuca, IL-32, VEGF, IL-17, MVD